TickerFiles

ACTUATE THERAPEUTICS, INC. 10-Q filing

Filed 2026-05-14 · Report date 2026-03-31 · 2026

View Original SEC Filing

Filing metadata

Accession number
0001683168-26-003909
Form type
10-Q
CIK
0001652935
Primary document
https://www.sec.gov/Archives/edgar/data/1652935/000168316826003909/actuate_i10q-033126.htm

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for ACTUATE THERAPEUTICS, INC..

Reported financial metrics

MetricCurrentPriorChange
Operating Income$-5.7M--
Net Income$-5.6M--
Eps Basic-0.24--
Eps Diluted-0.24--
Cash And Equivalents$8.1M--
Total Assets$8.9M--
Total Liabilities$5.1M--
Shareholders Equity$3.8M--
Operating Cash Flow$-5.0M--